The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
Abstract
BACKGROUND: The objective of the current study was to assess the correlations between cognitive function, fatigue, quality of life, and circulating cytokine levels in patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). METHODS: Fifty‐four patients with AML/MDS were seen for pretreatment evaluation of their cognitive function and symptoms. Fifty percent of the sample was reevaluated 1 month later, when response to protocol chemotherapy was assessed. RESULTS: A significant proportion of patients had impaired cognitive function prior to the institution of chemotherapy. Sixty‐five percent of patients also experienced significant fatigue. Levels of the circulating cytokines interleukin 1 (IL‐1), IL‐1 receptor antagonist (IL‐1RA), IL‐6, IL‐8, and tumor necrosis factor‐α (TNF‐α) were elevated highly compared with normal controls. Higher IL‐6 levels were associated with poorer executive function, whereas higher IL‐8 levels were associated with better memory performance. IL‐6, IL‐1RA, and TNF‐α levels were related to ratings of fatigue. Fatigue and cognitive dysfunction were unrelated. Hemoglobin levels were not associated significantly with either cognitive dysfunction or fatigue. Patients who obtained a complete response tended to have better fine motor control at baseline and lower circulating IL‐1 levels. Treatment did not have a significant impact on cognition, although fatigue levels tended to increase. CONCLUSIONS: Patients with AML/MDS are highly symptomatic and experience cognitive impairment and fatigue before the initiation of their treatment. The current results indicated a correlation between these symptoms and levels of circulating cytokines, providing some support to the hypothesis that cancer‐related symptoms are related at least in part to cytokine‐immunologic activation. Elucidation of immunologic correlates of symptoms will allow for targeted interventions. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
Neuropsychological assessment.
Cipolotti, L., & Warrington, E. K. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.6.655 · Cited by 3,234
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597
Measurement in Neurological Rehabilitation
Cole, M. (1993) · Neurology · doi:10.1212/wnl.43.2.459-b · Cited by 1,011
Multilingual Aphasia Examination
(2012) · SpringerReference · doi:10.1007/springerreference_183669 · Cited by 805
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Measurement In Neurological Rehabilitation
Harms, M. (1992) · Physiotherapy · doi:10.1016/s0031-9406(10)60484-1 · Cited by 530
Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., Wang, X. S., et al. (2003) · Cancer · doi:10.1002/cncr.11382 · Cited by 526
Self-citationExpression of chemokine receptors by subsets of neurons in the central nervous system
Horuk, R., Martin, A. W., Wang, Z., Schweitzer, L., Gerassimides, A., Guo, H., Lu, Z., Hesselgesser, J., Perez, H. D., Kim, J., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2882 · Cited by 385
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Self-citationMood and cognitive side effects of interferon-alpha therapy.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998) · PubMed · Cited by 312
Self-citationBehavioral Effects of Cytokines
Larson, S. J., & Dunn, A. J. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0643 · Cited by 296
Neuropsychological Assessment, 3rd Edition
Rosen, W. G. (1996) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.8.3.359 · Cited by 277
Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.
Waage, A., & Espevik, T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1987 · Cited by 242
Wechsler Adult Intelligence Scale
Luiselli, J., Happé, F., Hurst, H., Freeman, S., Goldstein, G., Mazefsky, C., Carter, A. S., Kaufman, A. S., Simmons, E. S., Eernisse, E. R., et al. (2013) · Encyclopedia of Autism Spectrum Disorders · doi:10.1007/978-1-4419-1698-3_101553 · Cited by 209
Cognitive deficits in patients with small cell lung cancer before and after chemotherapy
Meyers, C. A., Byrne, K. S., & Komaki, R. K. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00446-8 · Cited by 166
Self-citationPlata‐Saláman, C. R., & ffrench‐Mullen, J. M. H. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90029-w · Cited by 117
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma
Preti, H. A., Cabanillas, F., Talpaz, M., Tucker, S. L., Seymour, J. F., & Kurzrock, R. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00002 · Cited by 112
Seymour, J. F., Talpaz, M., Hagemeister, F. B., Cabanillas, F., & Kurzrock, R. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00352-x · Cited by 80
Neurological and Psychiatric Adverse Effects of Immunological Therapy
Meyers, C. A., & Valentine, A. D. (1995) · CNS Drugs · doi:10.2165/00023210-199503010-00006 · Cited by 76
Self-citationIL-2 and IL-6 secretion in dementia: correlation with type and severity of disease
Huberman, M., Sredni, B., Stern, L., Kott, E., & Shalit, F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00016-u · Cited by 62
The Expression of IL-6 and its Related Genes in Acute Leukemia
Sugiyama, H., Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Miyake, S., Hirata, M., & Kishimoto, T. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609067579 · Cited by 40
Ellison, M. D., & Merchant, R. E. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90112-k · Cited by 39
Behavioural effects of cytokines
Dantzer, R., Bluthé, R.-M., Kent, S., & KELLEY, K. W. (1992) · Elsevier eBooks · doi:10.1016/b978-0-08-041996-1.50012-1 · Cited by 34
Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease
Sherman, A. M., Jaeckle, K. A., & Meyers, C. A. (2002) · Cancer · doi:10.1002/cncr.10816 · Cited by 27
Self-citationBruserud, Ø., Nesthus, I., Bühring, H., & Pawelec, G. (1995) · Leukemia Research · doi:10.1016/0145-2126(94)00062-f · Cited by 19
Kurzrock, R., Wetzler, M., Estrov, Z. E., & Talpaz, M. (1995) · PubMed · Cited by 6
Cytokines and neuronal degeneration
Wollman, E. E., Kopmels, B., Bakalian, A., Delhaye‐Bouchaud, N., FRADELIZI, D., & Mariani, J. (1992) · Elsevier eBooks · doi:10.1016/b978-0-08-041996-1.50015-7 · Cited by 5
The rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
Cited by
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Immune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Extermann, M., Boler, I., Reich, R. R., Lyman, G. H., Brown, R. H., DeFelice, J., Levine, R. M., Lubiner, E. T., Reyes, P., Schreiber, F. J., et al. (2012) · Cancer · doi:10.1002/cncr.26646 · Cited by 1,143
Metadata
- Authors
- Meyers, C. A., Albitar, M., & Estey, E.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-06-22
- Volume
- 104
- Issue
- 4
- Pages
- 788-793
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1987694020
- Cited by
- 459
- References
- 30
- FWCI
- 13.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.